These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 27072241)

  • 1. Tumour suppressive effects of WEE1 gene silencing in neuroblastomas.
    Tashnizi AH; Jaberipour M; Razmkhah M; Rahnama S; Habibagahi M
    J Cancer Res Ther; 2016; 12(1):221-7. PubMed ID: 27072241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour suppressive effects of WEE1 gene silencing in breast cancer cells.
    Ghiasi N; Habibagahi M; Rosli R; Ghaderi A; Yusoff K; Hosseini A; Abdullah S; Jaberipour M
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6605-11. PubMed ID: 24377575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma.
    Bhattacharya A; Schmitz U; Wolkenhauer O; Schönherr M; Raatz Y; Kunz M
    Oncogene; 2013 Jun; 32(26):3175-83. PubMed ID: 22847610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic inhibition of the atypical kinase Wee1 selectively drives apoptosis of p53 inactive tumor cells.
    Pappano WN; Zhang Q; Tucker LA; Tse C; Wang J
    BMC Cancer; 2014 Jun; 14():430. PubMed ID: 24927813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma.
    Harris PS; Venkataraman S; Alimova I; Birks DK; Balakrishnan I; Cristiano B; Donson AM; Dubuc AM; Taylor MD; Foreman NK; Reigan P; Vibhakar R
    Mol Cancer; 2014 Mar; 13():72. PubMed ID: 24661910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1.
    Creevey L; Ryan J; Harvey H; Bray IM; Meehan M; Khan AR; Stallings RL
    Mol Cancer; 2013 Mar; 12():23. PubMed ID: 23531080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor suppressive effects of WEE1 gene silencing could not enhance immunopotentiation effects of CD80 and 4-1BBL co-stimulation in human T cells.
    Ghiasi N; Habibagahi M; Rosli R; Ghaderi A; Yusoff K; Hosseini A; Abdullah S; Jaberipour M
    J Cancer Res Ther; 2015; 11(4):708-16. PubMed ID: 26881506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-503 enhances the radiosensitivity of laryngeal carcinoma cells via the inhibition of WEE1.
    Ma H; Lian R; Wu Z; Li X; Yu W; Shang Y; Guo X
    Tumour Biol; 2017 Oct; 39(10):1010428317706224. PubMed ID: 29019284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of Wee1 kinase by a specific subset of microRNA in human sporadic pituitary adenomas.
    Butz H; Likó I; Czirják S; Igaz P; Khan MM; Zivkovic V; Bálint K; Korbonits M; Rácz K; Patócs A
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E181-91. PubMed ID: 20668041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions.
    Slipicevic A; Holth A; Hellesylt E; Tropé CG; Davidson B; Flørenes VA
    Gynecol Oncol; 2014 Oct; 135(1):118-24. PubMed ID: 25093290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of cyclin B1 and up-regulation of Wee1 by berberine promotes entry of leukemia cells into the G2/M-phase of the cell cycle.
    Lin CC; Lin SY; Chung JG; Lin JP; Chen GW; Kao ST
    Anticancer Res; 2006; 26(2A):1097-104. PubMed ID: 16619512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia.
    Porter CC; Kim J; Fosmire S; Gearheart CM; van Linden A; Baturin D; Zaberezhnyy V; Patel PR; Gao D; Tan AC; DeGregori J
    Leukemia; 2012 Jun; 26(6):1266-76. PubMed ID: 22289989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients.
    Magnussen GI; Hellesylt E; Nesland JM; Trope CG; Flørenes VA; Holm R
    BMC Cancer; 2013 Jun; 13():288. PubMed ID: 23767999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of RNA interference to elucidate the effect of MYCN on cell cycle in neuroblastoma.
    Woo CW; Tan F; Cassano H; Lee J; Lee KC; Thiele CJ
    Pediatr Blood Cancer; 2008 Feb; 50(2):208-12. PubMed ID: 17420990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional repression of WEE1 by Kruppel-like factor 2 is involved in DNA damage-induced apoptosis.
    Wang F; Zhu Y; Huang Y; McAvoy S; Johnson WB; Cheung TH; Chung TK; Lo KW; Yim SF; Yu MM; Ngan HY; Wong YF; Smith DI
    Oncogene; 2005 Jun; 24(24):3875-85. PubMed ID: 15735666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of Wee1 is associated with poor disease-free survival in malignant melanoma: potential for targeted therapy.
    Magnussen GI; Holm R; Emilsen E; Rosnes AK; Slipicevic A; Flørenes VA
    PLoS One; 2012; 7(6):e38254. PubMed ID: 22719872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma.
    Mir SE; De Witt Hamer PC; Krawczyk PM; Balaj L; Claes A; Niers JM; Van Tilborg AA; Zwinderman AH; Geerts D; Kaspers GJ; Peter Vandertop W; Cloos J; Tannous BA; Wesseling P; Aten JA; Noske DP; Van Noorden CJ; Würdinger T
    Cancer Cell; 2010 Sep; 18(3):244-57. PubMed ID: 20832752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics identified nuclear N-myc downstream-regulated gene 1 as a prognostic tissue biomarker candidate in renal cell carcinoma.
    Hosoya N; Sakumoto M; Nakamura Y; Narisawa T; Bilim V; Motoyama T; Tomita Y; Kondo T
    Biochim Biophys Acta; 2013 Dec; 1834(12):2630-9. PubMed ID: 23999030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle regulation by the Wee1 inhibitor PD0166285, pyrido [2,3-d] pyimidine, in the B16 mouse melanoma cell line.
    Hashimoto O; Shinkawa M; Torimura T; Nakamura T; Selvendiran K; Sakamoto M; Koga H; Ueno T; Sata M
    BMC Cancer; 2006 Dec; 6():292. PubMed ID: 17177986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient suppression of nuclear Cdc2 activity in response to ionizing radiation.
    Kim MJ; Lee JY; Lee SJ
    Oncol Rep; 2008 May; 19(5):1323-9. PubMed ID: 18425394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.